SD Biotechnologies Co., Ltd.

KOSDAQ:A217480 Stok Raporu

Piyasa değeri: ₩14.9b

SD Biotechnologies Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

SD Biotechnologies has a total shareholder equity of ₩19.1B and total debt of ₩59.1B, which brings its debt-to-equity ratio to 308.7%. Its total assets and total liabilities are ₩100.0B and ₩80.8B respectively.

Anahtar bilgiler

308.7%

Borç/özkaynak oranı

₩59.06b

Borç

Faiz karşılama oranın/a
Nakit₩4.83b
Eşitlik₩19.13b
Toplam yükümlülükler₩80.84b
Toplam varlıklar₩99.97b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

How Much Of SD Biotechnologies Co., Ltd. (KOSDAQ:217480) Do Insiders Own?

Feb 21
How Much Of SD Biotechnologies Co., Ltd. (KOSDAQ:217480) Do Insiders Own?

SD Biotechnologies' (KOSDAQ:217480) Stock Price Has Reduced 58% In The Past Three Years

Nov 25
SD Biotechnologies' (KOSDAQ:217480) Stock Price Has Reduced 58% In The Past Three Years

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: A217480's short term assets (₩34.9B) do not cover its short term liabilities (₩78.6B).

Uzun Vadeli Yükümlülükler: A217480's short term assets (₩34.9B) exceed its long term liabilities (₩2.3B).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: A217480's net debt to equity ratio (283.5%) is considered high.

Borcun Azaltılması: A217480's debt to equity ratio has increased from 8.3% to 308.7% over the past 5 years.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: A217480 has less than a year of cash runway based on its current free cash flow.

Tahmini Nakit Akışı: A217480 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.8% each year


Sağlıklı şirketleri keşfedin